{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,28]],"date-time":"2026-07-28T09:06:15Z","timestamp":1785229575302,"version":"3.55.0"},"reference-count":43,"publisher":"Xia & He Publishing","issue":"000","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2021,3,8]]},"DOI":"10.14218\/jcth.2020.00105","type":"journal-article","created":{"date-parts":[[2021,3,7]],"date-time":"2021-03-07T22:41:03Z","timestamp":1615156863000},"page":"000-000","source":"Crossref","is-referenced-by-count":5,"title":["Histone Deacetylase Inhibitors Romidepsin and Vorinostat Promote Hepatitis B Virus Replication by Inducing Cell Cycle Arrest"],"prefix":"10.14218","volume":"000","author":[{"given":"Yang","family":"Yang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yu","family":"Yan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhen","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jie","family":"Hu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kai","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ni","family":"Tang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaosong","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhi","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"5334","published-online":{"date-parts":[[2021,3,8]]},"reference":[{"key":"key20210307224051_JCTH-D-20-00105-b1","doi-asserted-by":"crossref","first-page":"154518","DOI":"10.1016\/j.cyto.2018.08.012","article-title":"Interferon signaling during Hepatitis B Virus (HBV) infection and HBV-associated hepatocellular carcinoma","volume":"124","author":"Mani","year":"2019","journal-title":"Cytokine"},{"key":"key20210307224051_JCTH-D-20-00105-b2","doi-asserted-by":"crossref","first-page":"1546","DOI":"10.1016\/S0140-6736(15)61412-X","article-title":"Estimations of worldwide prevalence of chronic hepatitis B virus infection: a systematic review of data published between 1965 and 2013","volume":"386","author":"Schweitzer","year":"2015","journal-title":"Lancet"},{"key":"key20210307224051_JCTH-D-20-00105-b3","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1128\/MMBR.64.1.51-68.2000","article-title":"Hepatitis B virus biology","volume":"64","author":"Seeger","year":"2000","journal-title":"Microbiol Mol Biol Rev"},{"key":"key20210307224051_JCTH-D-20-00105-b4","doi-asserted-by":"crossref","first-page":"672","DOI":"10.1016\/j.virol.2015.02.031","article-title":"Molecular biology of hepatitis B virus infection","volume":"479-480","author":"Seeger","year":"2015","journal-title":"Virology"},{"key":"key20210307224051_JCTH-D-20-00105-b5","doi-asserted-by":"crossref","first-page":"1972","DOI":"10.1136\/gutjnl-2015-309809","article-title":"HBV cccDNA: viral persistence reservoir and key obstacle for a cure of chronic hepatitis B","volume":"64","author":"Nassal","year":"2015","journal-title":"Gut"},{"key":"key20210307224051_JCTH-D-20-00105-b6","doi-asserted-by":"crossref","first-page":"823","DOI":"10.1002\/hep.27604","article-title":"Hepatitis B surface antigen genetic elements critical for immune escape correlate with hepatitis B virus reactivation upon immunosuppression","volume":"61","author":"Salpini","year":"2015","journal-title":"Hepatology"},{"key":"key20210307224051_JCTH-D-20-00105-b7","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1016\/S0016-5085(75)80054-0","article-title":"Serial studies of hepatitis-associated antigen and antibody in patients receiving antitumor chemotherapy for myeloproliferative and lymphoproliferative disorders","volume":"68","author":"Wands","year":"1975","journal-title":"Gastroenterology"},{"key":"key20210307224051_JCTH-D-20-00105-b8","doi-asserted-by":"crossref","first-page":"1297","DOI":"10.1053\/j.gastro.2017.02.009","article-title":"Hepatitis B reactivation associated with immune suppressive and biological modifier therapies: Current concepts, management strategies, and future directions","volume":"152","author":"Loomba","year":"2017","journal-title":"Gastroenterology"},{"key":"key20210307224051_JCTH-D-20-00105-b9","doi-asserted-by":"crossref","first-page":"2521","DOI":"10.1001\/jama.2014.15704","article-title":"Entecavir vs lamivudine for prevention of hepatitis B virus reactivation among patients with untreated diffuse large B-cell lymphoma receiving R-CHOP chemotherapy: a randomized clinical trial","volume":"312","author":"Huang","year":"2014","journal-title":"JAMA"},{"key":"key20210307224051_JCTH-D-20-00105-b10","doi-asserted-by":"crossref","first-page":"S156","DOI":"10.1002\/hep.22945","article-title":"Reactivation of hepatitis B","volume":"49","author":"Hoofnagle","year":"2009","journal-title":"Hepatology"},{"key":"key20210307224051_JCTH-D-20-00105-b11","doi-asserted-by":"crossref","first-page":"8797206","DOI":"10.1155\/2016\/8797206","article-title":"HDAC inhibitors as epigenetic regulators of the immune system: Impacts on cancer therapy and inflammatory diseases","volume":"2016","author":"Hull","year":"2016","journal-title":"Biomed Res Int"},{"key":"key20210307224051_JCTH-D-20-00105-b12","doi-asserted-by":"crossref","first-page":"10694","DOI":"10.1128\/JVI.01172-09","article-title":"Stimulus duration and response time independently influence the kinetics of lytic cycle reactivation of Epstein-Barr virus","volume":"83","author":"Countryman","year":"2009","journal-title":"J Virol"},{"key":"key20210307224051_JCTH-D-20-00105-b13","doi-asserted-by":"crossref","first-page":"508","DOI":"10.1093\/annonc\/mdv596","article-title":"Epstein-Barr virus reactivation in extranodal natural killer\/T-cell lymphoma patients: a previously unrecognized serious adverse event in a pilot study with romidepsin","volume":"27","author":"Kim","year":"2016","journal-title":"Ann Oncol"},{"key":"key20210307224051_JCTH-D-20-00105-b14","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1002\/ijc.29698","article-title":"Inhibition of class I histone deacetylases by romidepsin potently induces Epstein-Barr virus lytic cycle and mediates enhanced cell death with ganciclovir","volume":"138","author":"Hui","year":"2016","journal-title":"Int J Cancer"},{"key":"key20210307224051_JCTH-D-20-00105-b15","doi-asserted-by":"crossref","first-page":"2630","DOI":"10.3390\/ijms19092630","article-title":"Histone deacetylase inhibitors and diabetic kidney disease","volume":"19","author":"Hadden","year":"2018","journal-title":"Int J Mol Sci"},{"key":"key20210307224051_JCTH-D-20-00105-b16","doi-asserted-by":"crossref","first-page":"6782","DOI":"10.1074\/jbc.M807898200","article-title":"Suberoylanilide hydroxamic acid reactivates HIV from latently infected cells","volume":"284","author":"Contreras","year":"2009","journal-title":"J Biol Chem"},{"key":"key20210307224051_JCTH-D-20-00105-b17","doi-asserted-by":"crossref","first-page":"482","DOI":"10.1038\/nature11286","article-title":"Administration of vorinostat disrupts HIV-1 latency in patients on antiretroviral therapy","volume":"487","author":"Archin","year":"2012","journal-title":"Nature"},{"key":"key20210307224051_JCTH-D-20-00105-b18","doi-asserted-by":"crossref","first-page":"728","DOI":"10.1093\/infdis\/jiu155","article-title":"HIV-1 expression within resting CD4+ T cells after multiple doses of vorinostat","volume":"210","author":"Archin","year":"2014","journal-title":"J Infect Dis"},{"key":"key20210307224051_JCTH-D-20-00105-b19","doi-asserted-by":"crossref","first-page":"e1004473","DOI":"10.1371\/journal.ppat.1004473","article-title":"Activation of HIV transcription with short-course vorinostat in HIV-infected patients on suppressive antiretroviral therapy","volume":"10","author":"Elliott","year":"2014","journal-title":"PLoS Pathog"},{"key":"key20210307224051_JCTH-D-20-00105-b20","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/978-1-4939-6700-1_1","article-title":"NTCP-reconstituted in vitro HBV infection system","volume":"1540","author":"Sun","year":"2017","journal-title":"Methods Mol Biol"},{"key":"key20210307224051_JCTH-D-20-00105-b21","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1016\/j.antiviral.2017.11.006","article-title":"APOBEC3B edits HBV DNA and inhibits HBV replication during reverse transcription","volume":"149","author":"Chen","year":"2018","journal-title":"Antiviral Res"},{"key":"key20210307224051_JCTH-D-20-00105-b22","first-page":"543","article-title":"Effects of cell cycle on telomerase activity and on hepatitis B virus replication in HepG2 2.2.15 cells","volume":"3","author":"Huang","year":"2004","journal-title":"Hepatobiliary Pancreat Dis Int"},{"key":"key20210307224051_JCTH-D-20-00105-b23","doi-asserted-by":"crossref","first-page":"1519","DOI":"10.1053\/gast.1996.v110.pm8613059","article-title":"Effect of hepatocyte proliferation and cellular DNA synthesis on hepatitis B virus replication","volume":"110","author":"Ozer","year":"1996","journal-title":"Gastroenterology"},{"key":"key20210307224051_JCTH-D-20-00105-b24","doi-asserted-by":"crossref","first-page":"969","DOI":"10.3851\/IMP1840","article-title":"Risk of HBV reactivation according to viral status and treatment intensity in patients with hepatocellular carcinoma","volume":"16","author":"Jang","year":"2011","journal-title":"Antivir Ther"},{"key":"key20210307224051_JCTH-D-20-00105-b25","doi-asserted-by":"crossref","first-page":"1672","DOI":"10.1158\/1541-7786.MCR-09-0112","article-title":"Promyelocytic leukemia nuclear bodies link the DNA damage repair pathway with hepatitis B virus replication: implications for hepatitis B virus exacerbation during chemotherapy and radiotherapy","volume":"7","author":"Chung","year":"2009","journal-title":"Mol Cancer Res"},{"key":"key20210307224051_JCTH-D-20-00105-b26","doi-asserted-by":"crossref","first-page":"1618","DOI":"10.3324\/haematol.2009.008607","article-title":"Reactivation of DNA viruses in association with histone deacetylase inhibitor therapy: a case series report","volume":"94","author":"Ritchie","year":"2009","journal-title":"Haematologica"},{"key":"key20210307224051_JCTH-D-20-00105-b27","doi-asserted-by":"crossref","first-page":"398","DOI":"10.1002\/cbf.3359","article-title":"The histone deacetylase inhibitor panobinostat exerts anticancer effects on esophageal squamous cell carcinoma cells by inducing cell cycle arrest","volume":"36","author":"Cheng","year":"2018","journal-title":"Cell Biochem Funct"},{"key":"key20210307224051_JCTH-D-20-00105-b28","doi-asserted-by":"crossref","first-page":"823","DOI":"10.1053\/j.gastro.2006.01.001","article-title":"Hepatitis B virus replication is regulated by the acetylation status of hepatitis B virus cccDNA-bound H3 and H4 histones","volume":"130","author":"Pollicino","year":"2006","journal-title":"Gastroenterology"},{"key":"key20210307224051_JCTH-D-20-00105-b29","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1016\/j.lfs.2018.12.057","article-title":"miRNA-548ah promotes the replication and expression of hepatitis B virus by targeting histone deacetylase 4","volume":"219","author":"Xing","year":"2019","journal-title":"Life Sci"},{"key":"key20210307224051_JCTH-D-20-00105-b30","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.lfs.2019.03.010","article-title":"Histone deacetylases and acetylated histone H3 are involved in the process of hepatitis B virus DNA replication","volume":"223","author":"Zhang","year":"2019","journal-title":"Life Sci"},{"key":"key20210307224051_JCTH-D-20-00105-b31","doi-asserted-by":"crossref","first-page":"3885","DOI":"10.1007\/s00018-014-1656-6","article-title":"Histone deacetylase inhibitors and cell death","volume":"71","author":"Zhang","year":"2014","journal-title":"Cell Mol Life Sci"},{"key":"key20210307224051_JCTH-D-20-00105-b32","doi-asserted-by":"crossref","first-page":"3952","DOI":"10.3390\/ijms19123952","article-title":"Epigenetic targeting of autophagy via HDAC inhibition in tumor cells: Role of p53","volume":"19","author":"Mrakovcic","year":"2018","journal-title":"Int J Mol Sci"},{"key":"key20210307224051_JCTH-D-20-00105-b33","doi-asserted-by":"crossref","first-page":"678","DOI":"10.2967\/jnumed.113.126573","article-title":"P21-driven multifusion gene system for evaluating the efficacy of histone deacetylase inhibitors by in vivo molecular imaging and for transcription targeting therapy of cancer mediated by histone deacetylase inhibitor","volume":"55","author":"Hsieh","year":"2014","journal-title":"J Nucl Med"},{"key":"key20210307224051_JCTH-D-20-00105-b34","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1186\/1423-0127-18-96","article-title":"Dynamics of HBV cccDNA expression and transcription in different cell growth phase","volume":"18","author":"Chong","year":"2011","journal-title":"J Biomed Sci"},{"key":"key20210307224051_JCTH-D-20-00105-b35","doi-asserted-by":"crossref","first-page":"1498","DOI":"10.3748\/wjg.v21.i5.1498","article-title":"S-phase arrest after vincristine treatment may promote hepatitis B virus replication","volume":"21","author":"Xu","year":"2015","journal-title":"World J Gastroenterol"},{"key":"key20210307224051_JCTH-D-20-00105-b36","doi-asserted-by":"crossref","first-page":"12832","DOI":"10.1128\/JVI.01216-10","article-title":"Influenza A virus replication induces cell cycle arrest in G0\/G1 phase","volume":"84","author":"He","year":"2010","journal-title":"J Virol"},{"key":"key20210307224051_JCTH-D-20-00105-b37","doi-asserted-by":"crossref","first-page":"2748","DOI":"10.1002\/j.1460-2075.1996.tb00635.x","article-title":"The Epstein-Barr virus bZIP transcription factor Zta causes G0\/G1 cell cycle arrest through induction of cyclin-dependent kinase inhibitors","volume":"15","author":"Cayrol","year":"1996","journal-title":"EMBO J"},{"key":"key20210307224051_JCTH-D-20-00105-b38","doi-asserted-by":"crossref","first-page":"7989","DOI":"10.1128\/JVI.00280-11","article-title":"Hepatitis C virus infection causes cell cycle arrest at the level of initiation of mitosis","volume":"85","author":"Kannan","year":"2011","journal-title":"J Virol"},{"key":"key20210307224051_JCTH-D-20-00105-b39","doi-asserted-by":"crossref","first-page":"e00722","DOI":"10.1128\/JVI.00722-18","article-title":"Hepatitis B virus deregulates the cell cycle to promote viral replication and a premalignant phenotype","volume":"92","author":"Xia","year":"2018","journal-title":"J Virol"},{"key":"key20210307224051_JCTH-D-20-00105-b40","doi-asserted-by":"crossref","first-page":"e0131743","DOI":"10.1371\/journal.pone.0131743","article-title":"Doxorubicin activates hepatitis B virus replication by elevation of p21 (Waf1\/Cip1) and C\/EBP\u03b1 expression","volume":"10","author":"Chen","year":"2015","journal-title":"PLoS One"},{"key":"key20210307224051_JCTH-D-20-00105-b41","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1186\/s12967-020-02318-8","article-title":"HDACi mediate UNG2 depletion, dysregulated genomic uracil and altered expression of oncoproteins and tumor suppressors in B- and T-cell lines","volume":"18","author":"Iveland","year":"2020","journal-title":"J Transl Med"},{"key":"key20210307224051_JCTH-D-20-00105-b42","doi-asserted-by":"crossref","first-page":"5525","DOI":"10.1158\/1078-0432.CCR-18-3083","article-title":"Genetic polymorphisms predisposing the interleukin 6-induced APOBEC3B-UNG imbalance increase HCC risk via promoting the generation of APOBEC-signature HBV mutations","volume":"25","author":"Liu","year":"2019","journal-title":"Clin Cancer Res"},{"key":"key20210307224051_JCTH-D-20-00105-b43","doi-asserted-by":"crossref","first-page":"e12447","DOI":"10.1111\/cpr.12447","article-title":"Pharmacological or transcriptional inhibition of both HDAC1 and 2 leads to cell cycle blockage and apoptosis via p21Waf1\/Cip1 and p19INK4d upregulation in hepatocellular carcinoma","volume":"51","author":"Zhou","year":"2018","journal-title":"Cell Prolif"}],"container-title":["Journal of Clinical and Translational Hepatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.xiahepublishing.com\/2310-8819\/JCTH-2020-00105","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,10]],"date-time":"2026-07-10T18:19:42Z","timestamp":1783707582000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.xiahepublishing.com\/2310-8819\/JCTH-2020-00105"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,3,8]]},"references-count":43,"journal-issue":{"issue":"000","published-online":{"date-parts":[[2021,3,8]]},"published-print":{"date-parts":[[2021,3,8]]}},"alternative-id":["10.14218\/JCTH.2020.00105"],"URL":"https:\/\/doi.org\/10.14218\/jcth.2020.00105","relation":{},"ISSN":["2225-0719","2310-8819"],"issn-type":[{"value":"2225-0719","type":"print"},{"value":"2310-8819","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,3,8]]}}}